AAAAAA

   
Results: 1-9 |
Results: 9
Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone
Authors: Basson, BR Kinon, BJ Taylor, CC Szymanski, KA Gilmore, JA Tollefson, GD
Citation: Br. Basson et al., Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone, J CLIN PSY, 62(4), 2001, pp. 231-238
Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia
Authors: Kinon, BJ Basson, BR Gilmore, JA Tollefson, GD
Citation: Bj. Kinon et al., Long-term olanzapine treatment: Weight change and weight-related health factors in schizophrenia, J CLIN PSY, 62(2), 2001, pp. 92-100
Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia
Authors: Kinon, BJ Roychowdhury, SM Milton, DR Hill, AL
Citation: Bj. Kinon et al., Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia, J CLIN PSY, 62, 2001, pp. 17-21
Weight change and atypical antipsychotic treatment in patients with schizophrenia
Authors: Jones, B Basson, BR Walker, DJ Crawford, AMK Kinon, BJ
Citation: B. Jones et al., Weight change and atypical antipsychotic treatment in patients with schizophrenia, J CLIN PSY, 62, 2001, pp. 41-44
Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine
Authors: Kinon, BJ Basson, BR Gilmore, JA Malcolm, S Stauffer, VL
Citation: Bj. Kinon et al., Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine, J CLIN PSY, 61(11), 2000, pp. 833-840
The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia
Authors: David, SR Taylor, CC Kinon, BJ Breier, A
Citation: Sr. David et al., The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia, CLIN THER, 22(9), 2000, pp. 1085-1096
Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo
Authors: Tollefson, GD Dellva, MA Mattler, CA Kane, JM Wirshing, DA Kinon, BJ
Citation: Gd. Tollefson et al., Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo, J CL PSYCH, 19(5), 1999, pp. 435-443
Effects of chronic treatment with typical and atypical antipsychotic drugson the rat striatum
Authors: Lee, H Tarazi, FI Chakos, M Wu, HW Redmond, M Alvir, JM Kinon, BJ Bilder, R Creese, I Lieberman, JA
Citation: H. Lee et al., Effects of chronic treatment with typical and atypical antipsychotic drugson the rat striatum, LIFE SCI, 64(18), 1999, pp. 1595-1602
The routine use of atypical antipsychotic agents: Maintenance treatment
Authors: Kinon, BJ
Citation: Bj. Kinon, The routine use of atypical antipsychotic agents: Maintenance treatment, J CLIN PSY, 59, 1998, pp. 18-22
Risultati: 1-9 |